Skip to content

A comparative study between two spinal anaesthetic drugs Bupivacaine and Levobupivacaine for urological surgeries

A comparative evaluation of 0.5 percent hyperbaric levobupivacaine versus 0.5 percent hyperbaric bupivacaine for urological surgeries under spinal anaesthesia. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/05/087185
Enrollment
140
Registered
2025-05-20
Start date
Unknown
Completion date
Unknown
Last updated
2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system

Interventions

Intervention1: Hyperbaric Levobupivacaine: Hyperbaric Bupivacaine 3 ml will be given in spinal anaesthesia and we will observe the onset , duration of action of the drug and hemodynamic parameters. To

Sponsors

Dr Bhaskar Bezbaruah
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Patients planned for elective urological surgery under spinal anaesthesia 2.Patients with ASA Physical status 1 to 3 3.Patients who have given informed and written consent

Exclusion criteria

Exclusion criteria: 1.Refusal by patient 2.Any contraindication to spinal anaesthesia 3.Communication difficulties

Design outcomes

Primary

MeasureTime frame
To compare the time of onset of sensory block of each groupTimepoint: To compare the time of onset of sensory block within 24 hours of spinal anaesthesia

Secondary

MeasureTime frame
1.To compare the time of onset of motor block of each group. 2.To compare the duration of sensory and motor block of each group 3.To compare the effect of the two drugs on hemodynamic parameters. 4.To compare intra-operative adverse effects, if any Timepoint: within 24 hours of operation

Countries

India

Contacts

Public ContactDr Bhaskar Bezbaruah

Gauhati medical college and Hospital

sbsarma1@gmail.com9435046228

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026